Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS)PILERI, Alessandro; BRUNASSO, Alexandra Maria Giovanna; TILZ, Hemma et al.EJD. European journal of dermatology. 2011, Vol 21, Num 4, pp 624-625, issn 1167-1122, 2 p.Article

The rationale for choosing telmisartan and ramipril in the ONTARGET programmeUNGER, Thomas.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F3-F8Conference Paper

Vascular protection: telmisartan in the ONTARGET Trial ProgrammeDAGENAIS, Gilles R.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F47-F53Conference Paper

Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseasesSEEMAN, Tomas; DUSEK, Jiri; VONDRAK, Karel et al.American journal of hypertension. 2004, Vol 17, Num 5, pp 415-420, issn 0895-7061, 6 p., 1Article

CORD: Comparison of Recommended Doses of ace inhibitors and angiotensin II receptor blockersSPINAR, J; VITOVEC, J; SOUCEK, M et al.International journal of cardiology. 2010, Vol 144, Num 2, pp 293-294, issn 0167-5273, 2 p.Article

Stability of ramipril in the solvents of different pHHANYSOVA, L; VACLAVKOVA, M; DOHNAL, J et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 5, pp 1179-1183, issn 0731-7085, 5 p.Conference Paper

Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trialDiabetologia (Berlin). 2004, Vol 47, Num 9, pp 1519-1527, issn 0012-186X, 9 p.Article

On-line assay of the S-enantiomers of enalapril, ramipril and pentopril using a sequential injection analysis/amperometric biosensor systemSTEFAN, Raluca-Ioana; VAN STADEN, Jacobus F; BALA, Camelia et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 4, pp 889-892, issn 0731-7085, 4 p.Article

Contribution of bradykinin to the cardioprotective effects of ACE inhibitorsMURPHEY, L; VAUGHAN, D; BROWN, N et al.European heart journal supplements. 2003, Vol 5, Num A, issn 1520-765X, A37-A41Article

Mechanisms of cardiovascular risk reduction with ramipril : insights from HOPE and HOPE substudiesLONN, E; GERSTEIN, H. C; SMIEJA, M et al.European heart journal supplements. 2003, Vol 5, Num A, issn 1520-765X, A43-A48Article

Normal Pregnancy and Healthy Child After Continued Exposure to Gliclazide and Ramipril During PregnancyKOLAGASI, Oykun; SARI, Funda; AKAR, Munire et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 1, pp 147-149, issn 1060-0280, 3 p.Article

Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapySEEMAN, Tomas; GILIK, Jiri; VONDRAK, Karel et al.American journal of hypertension. 2007, Vol 20, Num 9, pp 990-996, issn 0895-7061, 7 p.Article

Is Ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction?TU, Karen; GUNRAJ, Nadia; MAMDANI, Muhammad et al.The American journal of cardiology. 2006, Vol 98, Num 1, pp 6-9, issn 0002-9149, 4 p.Article

Effect of ramipril on postrevascularization prevalence of angina and quality of lifeKJØLLER-HANSEN, Lars; STEFFENSEN, Rolf; GRANDE, Peer et al.International journal of cardiology. 2004, Vol 95, Num 2-3, pp 159-165, issn 0167-5273, 7 p.Article

Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failureKJØLLER-HANSEN, Lars; STEFFENSEN, Rolf; GRANDE, Peer et al.Journal of the American College of Cardiology. 2001, Vol 37, Num 5, pp 1214-1220, issn 0735-1097Article

ACE inhibitors to prevent end-stage renal disease: When to start and why possibly never to stop: A post hoc analysis of the rein trial resultsRUGGENENTI, Piero; PERNA, Annalisa; REMUZZI, Giuseppe et al.Journal of the American Society of Nephrology. 2001, Vol 12, Num 12, pp 2832-2837, issn 1046-6673Article

HOPE for all people with diabetes?MARSHALL, S. M.Diabetic medicine. 2000, Vol 17, pp 9-10, issn 0742-3071, SUP2Article

The effects of ramipril on sympathetic nervous system function in older patients with hypertensionLEE, C. C; SIDANI, M. A; HOGIKYAN, R. V et al.Clinical pharmacology and therapeutics. 1999, Vol 65, Num 4, pp 420-427, issn 0009-9236Article

Late treatment with ramipril increases survival in old spontaneously hypertensive ratsLINZ, W; WOHLFART, P; SCHOELKENS, B. A et al.Hypertension (Dallas, Tex. 1979). 1999, Vol 34, Num 2, pp 291-295, issn 0194-911XConference Paper

Contribution of bradykinin to the beneficial effects of ramipril in the fructose-fed ratERLICH, Y; ROSENTHAL, T.Journal of cardiovascular pharmacology. 1998, Vol 31, Num 4, pp 581-584, issn 0160-2446Article

Effects of ramipril on the hormone concentrations in serum of hypertensive patientsGRÖNROOS, P. E; IRJALA, K. M; VESALAINEN, R. K et al.European journal of clinical chemistry and clinical biochemistry. 1997, Vol 35, Num 6, pp 411-414, issn 0939-4974Article

Bioequivalence Study of Two Tablet Formulations of Ramipril in Healthy VolunteersALLEGRINI, Alessandro; NUZZO, Loredana; ZUCCHELLI, Mirco et al.Arzneimittel-Forschung. 2009, Vol 59, Num 8, pp 392-396, issn 0004-4172, 5 p.Article

Simultaneous Determination of Atorvastatin Calcium and Ramipril in Capsule Dosage Forms by High-Performance Liquid Chromatography and High-Performance Thin Layer ChromatographyPANCHAL, Hiral J; SUHAGIA, Bhanubhai N.Journal of AOAC International. 2010, Vol 93, Num 5, pp 1450-1457, issn 1060-3271, 8 p.Article

Randomized controlled trial of ACE-inhibitors and β-blockers with and without vasodilating activity in chronic glomerulonephritisERLEY, C. M; KLASS, M; KRÄMER, D et al.International journal of clinical pharmacology and therapeutics. 1996, Vol 34, Num 11, pp 504-509, issn 0946-1965Conference Paper

HOPE study impact on ACE inhibitors useHEMELS, Michiel E. H; BENNETT, Heather A; BONARI, Lori et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 5, pp 640-645, issn 1060-0280, 6 p.Article